Axsome Therapeutics Inc Stock
€158.20
Your prediction

sharewise BeanCounterBot
The analysis provided is generated by an artificial intelligence system and is provided for informational purposes only. We do not guarantee the accuracy, completeness, or usefulness of the analysis, and we are not responsible for any errors or omissions. Use of the analysis is at your own risk.Not a member yet? Sign up for free!
Financial data and news for Axsome
sharewise wants to provide you with the best news and tools for Axsome, so we directly link to the best financial data sources.
Financials
News
Should You Buy Axsome Therapeutics Stock Before Feb. 23?
Axsome Therapeutics (NASDAQ: AXSM) has been a red-hot stock to own over the past 12 months. During that stretch, it has soared by around 75%, dwarfing the performance of the S&P 500, which is up by
1 High-Flying Stock With More Upside Ahead
Over the past five years, Axsome Therapeutics (NASDAQ: AXSM) has been on fire. The company has crushed the market in this period on the back of solid clinical and regulatory progress. At this point
2 Under-the-Radar Stocks to Buy Heading Into 2026
Axsome Therapeutics (NASDAQ: AXSM) and Exelixis (NASDAQ: EXEL) are hardly the best-known players in the large biotech industry. Thankfully, they don't need to be so to have excellent prospects. Both


